九安医疗
(002432)
| 流通市值：166.65亿 | | | 总市值：194.59亿 |
| 流通股本：4.20亿 | | | 总股本：4.91亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,887,657,440.16 | 1,763,704,310.03 | 1,871,977,553.68 | 2,461,263,082.11 |
| 结算备付金 | - | 0 | - | - |
| 拆出资金 | - | 0 | - | - |
| 衍生金融资产 | - | 0 | - | - |
| 应收票据及应收账款 | 107,876,222.69 | 219,311,158.77 | 195,504,446.21 | 119,762,989.61 |
| 其中：应收票据 | 184,014.1 | 1,814,460.94 | 2,559,197.64 | 1,769,407.29 |
| 应收账款 | 107,692,208.59 | 217,496,697.83 | 192,945,248.57 | 117,993,582.32 |
| 应收款项融资 | - | 0 | - | - |
| 预付款项 | 58,667,970.7 | 31,401,157.78 | 15,334,111.41 | 14,007,110.29 |
| 应收保费 | - | 0 | - | - |
| 应收分保账款 | - | 0 | - | - |
| 应收分保合同准备金 | - | 0 | - | - |
| 其他应收款合计 | 64,673,049.2 | 90,187,468.27 | 100,642,166.51 | 86,027,162.18 |
| 其中:应收利息 | 36,908,974.53 | 68,067,430.4 | - | 71,068,162.83 |
| 应收股利 | - | 0 | - | - |
| 买入返售金融资产 | - | 0 | - | - |
| 存货 | 217,641,285.47 | 211,805,424.27 | 229,345,590.91 | 282,895,131.72 |
| 合同资产 | - | 0 | - | - |
| 一年内到期的非流动资产 | 3,070,478,953.71 | 388,509,584.13 | 112,139,722.22 | 111,142,847.22 |
| 其他流动资产 | 40,532,438.26 | 54,157,328.51 | 42,287,172.57 | 101,027,376.1 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 14,094,178,779.27 | 11,435,867,719.72 | 10,794,140,258.77 | 11,987,605,535.29 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | 0 | - | - |
| 债权投资 | 2,268,359,349.01 | 4,978,983,906.1 | 5,280,296,057.03 | 5,211,154,267.56 |
| 其他债权投资 | - | 0 | - | - |
| 长期应收款 | - | 0 | - | - |
| 长期股权投资 | 4,874,153.3 | 5,061,216 | 6,016,247.29 | 6,016,247.29 |
| 其他权益工具投资 | 413,333,192 | 306,399,526.56 | 275,901,910.92 | 287,985,478.82 |
| 其他非流动金融资产 | 7,025,515,111.43 | 6,528,576,300.66 | 6,411,337,034.83 | 4,499,025,167.97 |
| 投资性房地产 | - | 0 | - | - |
| 固定资产 | 326,149,207.66 | 336,402,105.09 | 326,723,384.02 | 339,746,120.78 |
| 在建工程 | 8,288,576.32 | 3,946,021.08 | 1,878,377.28 | 971,586.7 |
| 生产性生物资产 | - | 0 | - | - |
| 油气资产 | - | 0 | - | - |
| 使用权资产 | 19,070,351.41 | 23,737,503.18 | 29,851,901.99 | 36,777,775.33 |
| 无形资产 | 73,052,481.18 | 79,051,987.32 | 71,433,069.6 | 76,617,030.7 |
| 开发支出 | 8,644,300.68 | 8,464,974.19 | 20,480,911.26 | 18,086,514.55 |
| 商誉 | - | 0 | - | 0 |
| 长期待摊费用 | 10,839,105.04 | 9,242,837.52 | 4,783,822.16 | 4,577,047.27 |
| 递延所得税资产 | 63,120,863.03 | 63,136,766.28 | 66,114,045.14 | 55,022,810.33 |
| 其他非流动资产 | 149,094,792.74 | 169,356,761.14 | 85,709,892.2 | 95,531,207.52 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 10,370,341,483.8 | 12,512,359,905.12 | 12,580,526,653.72 | 10,631,511,254.82 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 24,464,520,263.07 | 23,948,227,624.84 | 23,374,666,912.49 | 22,619,116,790.11 |
| 流动负债: | | | | |
| 短期借款 | 1,260,000,000 | 1,350,000,000 | 1,150,000,000 | 1,200,000,000 |
| 向中央银行借款 | - | 0 | - | - |
| 吸收存款及同业存放 | - | 0 | - | - |
| 拆入资金 | - | 0 | - | - |
| 交易性金融负债 | - | 0 | - | - |
| 衍生金融负债 | - | 0 | - | - |
| 应付票据及应付账款 | 69,729,172.59 | 84,218,917.06 | 74,810,243.21 | 104,378,189.87 |
| 其中：应付票据 | - | 0 | - | - |
| 应付账款 | 69,729,172.59 | 84,218,917.06 | 74,810,243.21 | 104,378,189.87 |
| 预收款项 | - | 0 | - | - |
| 合同负债 | 38,607,586.53 | 33,971,651.16 | 33,388,370.14 | 44,459,840.43 |
| 卖出回购金融资产款 | - | 0 | - | - |
| 应付手续费及佣金 | - | 0 | - | - |
| 应付职工薪酬 | 58,105,798.45 | 31,250,743.66 | 27,687,108.22 | 56,457,715.96 |
| 应交税费 | 50,080,326.18 | 18,328,312.27 | 18,960,389.27 | 38,033,269.15 |
| 其他应付款合计 | 6,539,426.98 | 9,119,216.78 | 10,237,618.47 | 8,970,211.35 |
| 其中:应付利息 | - | - | 99,267.28 | - |
| 应付分保账款 | - | 0 | - | - |
| 保险合同准备金 | - | 0 | - | - |
| 代理买卖证券款 | - | 0 | - | - |
| 代理承销证券款 | - | 0 | - | - |
| 一年内到期的非流动负债 | 295,987,703.59 | 178,930,582.46 | 81,061,455.95 | 64,339,917.36 |
| 其他流动负债 | 690,184.85 | 493,140.98 | 482,375.56 | 571,178.37 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,779,740,199.17 | 1,706,312,564.37 | 1,396,627,560.82 | 1,517,210,322.49 |
| 非流动负债: | | | | |
| 长期借款 | 1,597,000,000 | 1,778,000,000 | 1,580,000,000 | 295,000,000 |
| 应付债券 | - | 0 | - | - |
| 租赁负债 | 12,684,709.24 | 14,804,297.39 | 16,572,643.75 | 18,592,040.4 |
| 长期应付款 | - | 0 | - | - |
| 长期应付职工薪酬 | - | 0 | - | - |
| 预计负债 | - | 0 | - | - |
| 递延收益 | 10,964,448.68 | 11,760,749.5 | 12,316,615.78 | 13,340,638.85 |
| 递延所得税负债 | 1,042,590,586.71 | 984,993,342.32 | 953,316,396.16 | 950,562,680 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,663,239,744.63 | 2,789,558,389.21 | 2,562,205,655.69 | 1,277,495,359.25 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,442,979,943.8 | 4,495,870,953.58 | 3,958,833,216.51 | 2,794,705,681.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 490,621,332 | 490,307,069 | 488,811,438 | 488,289,622 |
| 其他权益工具 | - | 0 | - | - |
| 资本公积 | 2,114,494,646.58 | 2,088,488,399.11 | 2,059,838,175.13 | 2,043,259,747.04 |
| 减:库存股 | 2,286,268,307.62 | 2,286,268,307.62 | 1,889,507,314.49 | 1,106,635,383.25 |
| 其他综合收益 | 870,190,404.09 | 1,154,644,539.5 | 1,030,937,327.05 | 1,000,559,927.98 |
| 专项储备 | - | 0 | - | - |
| 盈余公积 | 189,910,161.1 | 189,910,161.1 | 189,910,161.1 | 189,910,161.1 |
| 一般风险准备 | - | 0 | - | - |
| 未分配利润 | 17,893,949,377.75 | 17,127,067,178.58 | 16,861,417,589.53 | 16,613,988,742.94 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 19,272,897,613.9 | 18,764,149,039.67 | 18,741,407,376.32 | 19,229,372,817.81 |
| 少数股东权益 | 748,642,705.37 | 688,207,631.59 | 674,426,319.66 | 595,038,290.56 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 20,021,540,319.27 | 19,452,356,671.26 | 19,415,833,695.98 | 19,824,411,108.37 |
| 负债和股东权益合计 | 24,464,520,263.07 | 23,948,227,624.84 | 23,374,666,912.49 | 22,619,116,790.11 |
| 公告日期 | 2024-10-31 | 2024-08-30 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |